Santhera Pharmaceuticals Holding AG

NEW
LTS:0QN1 (Switzerland)  
CHF 15.9 +1.0258 (+6.9%) Sep 3
At Loss
Market Cap:
CHF 238.20M ($ 293.36M)
Enterprise V:
CHF 264.70M ($ 326.01M)
Volume:
9.03K
Avg Vol (2M):
9.72K
Trade In:
Volume:
9.03K
At Loss

Santhera Pharmaceuticals Holding AG (LTS:0QN1) Dividend

Santhera Pharmaceuticals Holding AG (LTS:0QN1) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -26.7%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: LTS:0QN1 Dividend

Does Santhera Pharmaceuticals Holding AG (LTS:0QN1) pay a dividend?

Santhera Pharmaceuticals Holding AG (LTS:0QN1) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Santhera Pharmaceuticals Holding AG pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Santhera Pharmaceuticals Holding AG has returned capital to shareholders via buybacks at a rate of -26.7% over the past 3 years.

What are dividend-paying alternatives to Santhera Pharmaceuticals Holding AG?

For dividend-paying alternatives in Santhera Pharmaceuticals Holding AG's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.